•
Jun 30, 2018

Jazz Pharmaceuticals Q2 2018 Earnings Report

Total Revenue
$500M
Previous year: $394M
+26.9%
EPS
$3.49
Previous year: $2.56
+36.3%
Gross Profit
$466M
Previous year: $366M
+27.4%
Cash and Equivalents
$485M
Previous year: $239M
+102.8%
Total Assets
$5.35B
Previous year: $4.8B
+11.3%

Jazz Pharmaceuticals

Jazz Pharmaceuticals